University Of Leeds Opens New Process Development Laboratory
University of Leeds has a new laboratory, which will focus on making small scale process development more greener, cheaper and effective. The laboratory was built with an investment
The US Food and Drug Administration (FDA) has approved Pfizer’s Tukysa (tucatinib) along with pertuzumab and trastuzumab as a maintenance therapy for breast cancer.
Schreiner MediPharm’s transparent-Hologram-Seal is set to provide evidence against tampering and counterfeiting of drugs. The hologram has been helpful in ensuring packaged pharmaceutical safety of drugs. Reportedly, the
Keryx Biopharmaceuticals (Keryx) has received FDA Fast Track designation for KRX-0401 (Perifosine), an oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of relapsed/refractory